Stockscreener 앱 받기
9.60
9.46%
0.83
시간 외 거래:
9.50
-0.10
-1.04%
전일 마감가:
$8.77
열려 있는:
$8.94
하루 거래량:
5.45M
Relative Volume:
1.98
시가총액:
$1.13B
수익:
$2.35B
순이익/손실:
$-74.42M
주가수익비율:
-10.21
EPS:
-0.94
순현금흐름:
$150.93M
1주 성능:
+3.23%
1개월 성능:
-1.74%
6개월 성능:
-7.96%
1년 성능:
-70.08%
1일 변동 폭
$8.795
$9.72
1주일 범위
$8.57
$9.72
52주 변동 폭
$7.06
$33.23
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
EVH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
9.60 | 1.05B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Published on: 2025-08-20 23:34:49 - thegnnews.com
Evolent Health to offer $140M in convertible notes, Targets 2025 debt, stock buyback - MSN
Technical Heatmap Flags Evolent Health Inc. for WatchJuly 2025 Intraday Action & Low Risk High Reward Ideas - beatles.ru
Evolent prices $145 million convertible notes offering at 4.50% By Investing.com - Investing.com South Africa
Evolent Health Upsizes Convertible Notes Offering - TipRanks
Shareholders That Lost Money on Evolent Health, Inc.(EVH) Should Contact Levi & Korsinsky about Securities Fraud InvestigationEVH - ACCESS Newswire
Evolent Health prices convertible notes offering - MSN
Evolent Health Announces Pricing Of Oversubscribed And Upsized $145.0 Million Of Convertible Senior Notes Due 2031 To Repurchase Existing Notes And Class A Common Stock - MarketScreener
Evolent prices $145 million convertible notes offering at 4.50% - Investing.com
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock - PR Newswire
Evolent Health (EVH) Bolsters Management Team - MSN
Evolent Health announces $140M convertible senior notes offering - TipRanks
Evolent Health announces $140 million convertible notes offering - Investing.com
Evolent Health announces proposed offering of $140 million of convertible senior notes - MarketScreener
$140M Debt Offering: Evolent Health Launches Convertible Notes to Refinance Debt and Buy Back Stock - Stock Titan
Lost Money on Evolent Health, Inc.(EVH)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
What machine learning models say about Evolent Health Inc.2025 Fundamental Recap & Accurate Trade Setup Notifications - Newser
Understanding Evolent Health Inc.’s price movement2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Evolent Health Inc. stock trendline breakdownJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
Will Evolent Health Inc. continue its uptrendPortfolio Return Report & Weekly High Momentum Picks - Newser
Should you buy the dip on Evolent Health Inc.Market Activity Report & Growth Focused Stock Reports - thegnnews.com
Evolent Health’s Earnings Call: Balancing Growth and Challenges - MSN
Tools to assess Evolent Health Inc.’s risk profile2025 Market Overview & Breakout Confirmation Alerts - Newser
Evolent Health, Inc. (EVH) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
Engaged Capital's Q2 Moves: Freshpet Stake, Evolent Health Boost, Portillo's Reduction - AInvest
An Investigation Has Commenced on Behalf of Evolent Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your EVH Losses - ACCESS Newswire
5 Insightful Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
How Evolent Health’s Steep Revenue Drop and Forecast Will Impact EVH Investors - simplywall.st
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience - Investing.com India
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know - Yahoo Finance
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience By Investing.com - Investing.com India
Shareholder Rights Advocates at Levi & Korsinsky Investigate Evolent Health, Inc. (EVH) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Evolent Health at Canaccord Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Is This the Dip to Buy in Evolent Health Inc.Weekly Stock Recap & Low Volatility Stock Recommendations - 선데이타임즈
Evolent Health, Inc. (NYSE:EVH) Q2 2025 Earnings Call Transcript - Insider Monkey
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - TradingView
EVH ACTIVE INVESTIGATION: Contact Levi & Korsinsky If You Lost Money On Your Evolent Health, Inc. investment - ACCESS Newswire
Candlestick Reversal Detected on Evolent Health Inc.’s ChartFast Gaining Stock Screener Reports Released - beatles.ru
EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue - Yahoo Finance
Evolent Health, Inc. SEC 10-Q Report - TradingView
Lost Money on Evolent Health, Inc.(EVH)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Evolent Health’s Strong Financial Performance and Optimistic Future Outlook Earns Buy Rating - TipRanks
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $14 - 富途牛牛
Further Weakness as Evolent Health (NYSE:EVH) Drops 9.8% This Week, Taking Three-year Losses to 74% - 富途牛牛
How volatile is Evolent Health Inc. stockCapital Doubling Stock Strategy - mustnews.co.kr
Evolent Health's Strategic Position in the Evolving Managed Care Landscape - AInvest
Evolent Health, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:EVH) - Seeking Alpha
Should Evolent Health's (EVH) Declining Sales and Rising Losses Prompt Investor Reassessment of 2025 Outlook? - simplywall.st
Protect Your Investment: Contact Levi & Korsinsky About the Evolent Health, Inc. (EVH) Investigation - TradingView
Evolent Health (EVH) Stock Falls 13.9% on Disappointing Q2 ResultsNews and Statistics - IndexBox
Why Evolent Health (EVH) Stock Is Nosediving - TradingView
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.72%
0.81%
자본화:
|
볼륨(24시간):